Envue Medical Inc.
13F holders, Q3 2025 (September 30)6holders
$5.64avg. 13F price*
At the end of Q3 2025, 6 institutions reported holding Envue Medical Inc. in their 13F filings. The largest holders were Morgan Stanley ($6K), Tower Research Capital LLC (TRC) ($4K) and UBS Group AG ($198).
- Company
- Envue Medical Inc.
- Filed as
- NANOVIBRONIX INC (Q3 2025)
- CUSIP
- 63008J884
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $9K |
| Exits | 0 | $0 |
Ownership 6 holders
| Morgan Stanley | 0.00% | New | 1,000 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 627 | $4K |
| UBS Group AG | 0.00% | New | 35 | $198 |
| SBI Securities Co., Ltd. | 0.00% | New | 15 | $85 |
| Bank of America Corp. | 0.00% | New | 6 | $34 |
| Citigroup Inc. | 0.00% | New | 1 | $6 |
"% of holder's portfolio" is ENVUE MEDICAL INC.'s weight in each manager's 13F, not the share of Envue Medical Inc. the manager owns.